A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Name: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Published: 2016
License: Public Domain

Ludwig Institute for Cancer Research · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

breast-cancer melanoma prostate-cancer

head and neck squamous cell carcinoma, breast cancer, sarcoma, merkel cell carcinoma, cutaneous t-cell lymphoma, melanoma, renal cancer, bladder cancer, prostate cancer, testicular cancer, solid tumor, durvalumab

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1008582
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.